Axa Investment Managers has hired Linden Thomson as a portfolio manager in the Axa Framlington Healthcare team.
She has seven years' experience in the healthcare sector, having spent five years at Goldman Sachs within the global investment research division, where she was one of two analysts on the EU biotechnology research team.
Mark Beveridge, global head of Axa Framlington, said: 'Equity investors have traditionally thought of the healthcare sector as a defensive play, but factors such as the reform of healthcare provision in the US have created new opportunities for outperformance.
'We have a strong track record in achieving long-term capital growth in this area. Linden’s diversified skill set – encompassing bottom-up, fundamental stock research and analysis of the global pharmaceuticals and biotechnology sectors and portfolio construction - makes her a natural fit to join us and we look forward to having her on board.'